Your Article Summary
See Latest ArticlesClinical Challenges in Addressing Resistance to Antimicrobial Drugs in the Twenty-First Century
Clinical Pharmacology & Therapeutics, 07/02/09
Septimus EJ et al. - Among the gram-positive pathogens, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus species are the biggest threats. The situation is even more alarming with respect to gram-negative pathogens, especially because there are currently no late clinical trials involving new anti-infective drugs that are active against these pathogens.
EJ Septimus, 07/06/09
| This article highlights a growing and seriuos challenge which shuold be included in any health care reform. To date, the current proposals on health care reform have failed to adequately address antimicrobial resistance or prevention of hospital infections. Just providing coverage without taking out the waste and harm in our system will not deliver the quality of care politicians always talk about. One of the greatest advances in public health in the last century has been vaccine-preventable diseases and the development of antibiotics to treat seriuos infections. Isn't it ironic that on both these fronts we are now going the wrong direction! |
Related Articles
Food Safety: Human Health Consequences of Use of Antimicrobial Agents in Aquaculture
Clinical Infectious Diseases, 10/07/09
Relevance Score: 89%
Optimizing Antimicrobial Therapy in Sepsis and Septic Shock
Critical Care Clinics, 11/06/09
Relevance Score: 87%
Surmounting antimicrobial resistance in the Millennium Superbug: Staphylococcus aureus
Central European Journal of Medicine, 10/30/09
Relevance Score: 87%
Topical Antimicrobial Therapy for Treating Chronic Wounds
Clinical Infectious Diseases, 10/29/09
Relevance Score: 87%
Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics
Current Opinion in Infectious Diseases, 11/02/09
Relevance Score: 85%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09
Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities
Phytotherapy Research, 12/09/09
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
The Lancet - Early Online Publication, 12/09/09
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Reduction of blood pressure in patients with treatment-resistant hypertension
Expert Opinion in Pharmacotherapy, 12/09/09
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09